What is Tectonic Therapeutics's return on equity?

Tectonic Therapeutics (TECX) reported return on equity of -31.4% in Q1 2026.

What is the long-term trend for Tectonic Therapeutics's return on equity?

Over 2 years (2020 to 2025), Tectonic Therapeutics's return on equity has grown at a -16.6% compound annual growth rate (CAGR), from -54.4% to -37.8%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Tectonic Therapeutics TECX Return on equity

Return on equity at other companies

ALN

Alnylam PharmaceuticalsALNY

66.9%—

Septerna, Inc.SEPN

-12.2%—

RegenxbioRGNX

-196.4%-288pp

Gyre Therapeutics, Inc.GYRE

8.2%+4.2pp

Opko HealthOPK

-16.9%-21.7pp

Ginkgo BioworksDNA

-55.8%-1.8pp

Other financials

Income statement

See full

Operating income-$27.3M-49.2%

Net income-$25.2M-58.7%

EPS (diluted)-$1.34-44.1%

Balance sheet

See full

Cash & equivalents$236.9M-22.8%

Total debt$4.9M+86.1%

Total equity$230.4M-23.5%

Total assets$246.6M-21.7%

Cash flow

See full

Operating cash flow-$18.4M-40.7%

CapEx$19.0K-29.6%

Free cash flow-$18.4M-40.6%

Valuation

See full

Market cap$585.51M+58.3%

Enterprise value$353.51M+438%

Returns & leverage

See full

Debt / equity0×0.0×

Current ratio18.5×-4.4×

Where this comes from

Calculated from Tectonic Therapeutics’s reported figures.

net income/total stockholders equity=-31.4%

Based on trailing twelve months.

The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tectonic Therapeutics's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Tectonic Therapeutics's return on equity?: Tectonic Therapeutics (TECX) reported return on equity of -31.4% in Q1 2026.
What is the long-term trend for Tectonic Therapeutics's return on equity?: Over 2 years (2020 to 2025), Tectonic Therapeutics's return on equity has grown at a -16.6% compound annual growth rate (CAGR), from -54.4% to -37.8%.
What does return on equity mean?: Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.